|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61M 5/28 | (2006.01) | ||
| A61M 5/31 | (2006.01) | ||
| A61M 5/315 | (2006.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61P 27/02 | (2006.01) |
| (11) | Number of the document | 3777834 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20198921.7 |
| Date of filing the European patent application | 2013-05-30 | |
| (97) | Date of publication of the European application | 2021-02-17 |
| (45) | Date of publication and mention of the grant of the patent | 2022-02-16 |
| (46) | Date of publication of the claims translation | 2022-05-25 |
| (30) | Number | Date | Country code |
| 12170628 | 2012-06-01 | EP |
| (72) |
BRYANT, Andrew , CH
BUETTGEN, Heinrich , CH
PAPST, Wolfgang , CH
PICCI, Marie , CH
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Švirkštas |
| SYRINGE |
| Payment date | Validity (years) | Amount | |
| 2022-04-22 | 10 | 231.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-05-30 |